Inactive Instrument

Other languages Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Other languages

Unlock all the news: Be the first to know and act before the market!

Graphite Bio, Inc. Announces Executive Changes	23/08/23
Jounce Therapeutics, Inc. Announces Board Changes	04/05/23
Concentra Biosciences, LLC completed the acquisition of Jounce Therapeutics, Inc. from Tang Capital Management, LLC and others.	02/05/23
Redx confirms Jounce deal lapses, Tirupati seals deal	03/04/23
Redx Pharma Shares Fall 5% as Merger With Jounce Therapeutics Fails	03/04/23
Jounce Therapeutics, Inc. Expects Resignation of Elizabeth Trehu as Chief Medical Officer	30/03/23
Sector Update: Health Care Stocks Higher in Afternoon Trading	27/03/23
European Stock Markets Close Higher Monday as First Citizens BancShares' Planned Acquisition of Silicon Valley Bank Assets, Deposits Eases Banking Crisis Fears	27/03/23
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs	27/03/23
Redx Pharma Says Jounce Therapeutics Terminated Merger Deal; Shares Plunge 19%	27/03/23
Jounce Therapeutics Agrees to be Acquired by Concentra Biosciences	27/03/23
Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer	27/03/23
Jounce Therapeutics, Inc. completed the acquisition of Redx Pharma Plc from a group of sellers and other shareholders.	26/03/23
Jounce Therapeutics, Inc. Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer	16/03/23
Sector Update: Health Care Stocks' Late Recovery Stalls	15/03/23
Sector Update: Health Care Stocks Moderately Lower	15/03/23
Top Midday Gainers	15/03/23
Sector Update: Health Care Stocks Retreat Pre-Bell Wednesday	15/03/23
Redx Pharma Says Merger Target Jounce Therapeutics Received New Takeover Proposal; Stock Surges 34%	15/03/23
Sector Update: Health Care	15/03/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Other languages

Filters